RhumbLine Advisers
RDY icon

RhumbLine Advisers’s Dr. Reddy's Laboratories RDY Stock Holding History

RhumbLine Advisers’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.43M Buy
236,973
+5,240
+2% +$70.7K ﹤0.01% 1648
2026
Q1 		$3.21M Sell
231,733
-37,644
-14% -$524K ﹤0.01% 1618
2025
Q4 		$3.78M Sell
269,377
-8,557
-3% -$120K ﹤0.01% 1541
2025
Q3 		$3.89M Sell
277,934
-89,865
-24% -$1.29M ﹤0.01% 1562
2025
Q2 		$5.53M Buy
367,799
+24,510
+7% +$350K ﹤0.01% 1353
2025
Q1 		$4.53M Sell
343,289
-86,773
-20% -$1.2M ﹤0.01% 1409
2024
Q4 		$6.79M Buy
430,062
+44,722
+12% +$672K 0.01% 1257
2024
Q3 		$6.12M Buy
385,340
+7,125
+2% +$115K 0.01% 1319
2024
Q2 		$5.76M Sell
378,215
-93,910
-20% -$1.35M 0.01% 1311
2024
Q1 		$6.93M Sell
472,125
-6,410
-1% -$93.6K 0.01% 1244
2023
Q4 		$6.66M Buy
478,535
+31,620
+7% +$423K 0.01% 1258
2023
Q3 		$5.98M Buy
446,915
+2,185
+0.5% +$29.6K 0.01% 1248
2023
Q2 		$5.61M Buy
+444,730
New +$5.19M 0.01% 1307
2013
Q3 		– Sell
-301,500
Closed -$2.28M – 2987
2013
Q2 		$2.28M Buy
+301,500
New +$2.2M 0.01% 1217

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

RhumbLine Advisers's RDY Position: Q2 2026 in Review

RhumbLine Advisers increased its Dr. Reddy's Laboratories (RDY) stake by 2.3% in Q2 2026, buying an estimated $70.7K and bringing the position to 236,973 shares worth $3.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

RhumbLine Advisers first reported a position in RDY in Q2 2013 and has held it in 14 quarters since. The position peaked at $6.93M in Q1 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • RhumbLine Advisers held 236,973 shares of Dr. Reddy's Laboratories worth $3.43M as of Q2 2026.
  • RhumbLine Advisers bought 5,240 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $70.7K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1648 holding.
  • RhumbLine Advisers first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 14 quarters since.
  • RhumbLine Advisers's Dr. Reddy's Laboratories position peaked at $6.93M in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.